US President Donald Trump announces agreements with drug makers Eli Lilly and Novo Nordisk.

White House’s landmark deal with Novo Nordisk and Eli Lilly will cut costs from at least $1,000 to about $350

The deal also means Medicare will start covering obesity drugs for some patients for the first time beginning next year.